ARTELO BIOSCIENCES, INC. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Artelo Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Artelo Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.2M, a 54.3% increase year-over-year.
  • Artelo Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$9.54M, a 6.2% increase year-over-year.
  • Artelo Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$9.93M, a 3.47% increase from 2022.
  • Artelo Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$10.3M, a 9.24% decline from 2021.
  • Artelo Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$9.42M, a 101% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9.93M +$357K +3.47% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$10.3M -$870K -9.24% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$9.42M -$4.73M -101% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$4.69M -$1.48M -46% Sep 1, 2019 Aug 31, 2020 10-K 2021-11-29
2019 -$3.21M -$866K -37% Sep 1, 2018 Aug 31, 2019 10-K 2020-11-04
2018 -$2.34M -$2.11M -907% Sep 1, 2017 Aug 31, 2018 10-K/A 2019-12-18
2017 -$233K -$203K -684% Sep 1, 2016 Aug 31, 2017 10-K 2018-11-29
2016 -$29.7K -$14.4K -94.8% Sep 1, 2015 Aug 31, 2016 10-K 2017-11-29
2015 -$15.2K +$28.00 +0.18% Sep 1, 2014 Aug 31, 2015 10-K 2016-11-29
2014 -$15.3K Sep 1, 2013 Aug 31, 2014 10-K 2015-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.